ReviewDrug design, development and therapy2021

Profile of Enfortumab Vedotin in the Treatment of Urothelial Carcinoma: The Evidence to Date.

Mohamad Moussa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.